Toronto, Ontario–(Newsfile Corp. – June 3, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO“ or the “Company“), a leading provider of medical cannabis products...
Net revenue for Q1 2022 was $6.9 million VIVO continues to pursue its international expansion strategy which now represents >50% of cannabis revenue Canadian Launch of...
Net revenue for Q4 2021 was $6.9 million; Net revenue for 2021 was $25 million. In February 2021, closed a $7.2 million equity raise to help...
Toronto, Ontario–(Newsfile Corp. – February 11, 2022) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products...
Toronto, Ontario–(Newsfile Corp. – December 21, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“) is pleased to announce the appointment of...
Toronto, Ontario–(Newsfile Corp. – November 23, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and...
Toronto, Ontario–(Newsfile Corp. – November 19, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products...
Net revenue $6.2 million Net loss reduced to $1.1 million; EBITDA loss reduced to $2.1 million First shipment to Germany completed; Australia sales $2.2 million Toronto,...
Toronto, Ontario–(Newsfile Corp. – November 3, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading provider of medical cannabis products and...
Toronto, Ontario–(Newsfile Corp. – October 21, 2021) – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) (“VIVO” or the “Company“), a leading medical cannabis company and holder of...